ARIUS RESEARCH
ARIUS Research, Inc., a biotechnology company, engages in the discovery and development of antibody therapeutics primarily focusing on breast, prostate, ovarian, colorectal, pancreatic and lung cancers, leukemia, and melanoma. It identifies monoclonal antibodies targeting various cancer indications through its technology platform, FunctionFIRST. The company's product pipeline includes CD63 program that is in preclinical studies for various cancer indications; ARH460-16-2, an antibody targeting t... he cancer stem cell antigen CD44; AR36A36.11.1 and AR10A304.7, which targets the complement-inhibitory molecule CD59; AR47A6.4.2 and AR52A301.5, which are monoclonal antibodies directed to the cancer-associated protein TROP-2 that is homologous to human EpCAM, an another cell surface cancer related protein; and AR40A746.2.3 that targets leukemia cancer stem cells. It also has antibody programs targeting the MCSP antigen and 37LRP. ARIUS has partnerships with Oxford BioMedica plc, Xerion Pharmaceuticals AG, PDL BioPharma, Inc., Medarex, Inc., Genentech, Inc., and Takeda Pharmaceutical Company Limited. The company was founded in 1999 and is based in Toronto, Canada. As of September 23, 2008, Arius Research Inc. operates as a subsidiary of Roche Holding AG.
ARIUS RESEARCH
Industry:
Biotechnology Health Care Hospital Therapeutics
Founded:
1999-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.ariusresearch.com
Total Employee:
11+
Status:
Closed
Contact:
416-862-2323
Total Funding:
23.5 M USD
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Intradigm Corporation
Intradigm Corporation is a biotechnology company developing systematic RNA interference therapeutics.
Lenstec
Lenstec is a biotechnology company located in Saint Petersburg.
ORGANIC GENOMICS
ORGANIC GENOMICS is a biotechnology company for developing health care products of therapeutic proteins.
Current Employees Featured
Founder
Investors List
Efficacy Capital
Efficacy Capital investment in Venture Round - Arius Research
Xmark Opportunity Funds
Xmark Opportunity Funds investment in Venture Round - Arius Research
OrbiMed
OrbiMed investment in Venture Round - Arius Research
Xmark Asset Management
Xmark Asset Management investment in Venture Round - Arius Research
Official Site Inspections
http://www.ariusresearch.com
- Host name: lb-182-253.above.com
- IP address: 103.224.182.253
- Location: Australia
- Latitude: -33.494
- Longitude: 143.2104
- Timezone: Australia/Sydney